Your browser is out of date.

You are currently using Internet Explorer 7/8/9, which is not supported by our site. For the best experience, please use one of the latest browsers.

In this release from Pharmaceutical Commerce, Varcode is featured as one of the leading technology companies collaborating with diagnostic firms on new testing solutions. Varcode has developed lateral flow assays (LFAs) or remote testing of SARS-CoV-2 antibody presence. LFAs are an established method of performing a test; a body fluid (such as blood) interacts with an agent that in turn causes a line of color to appear within a test strip. 

The test strip can be incorporated into Varcode’s barcode assembly, and together the test and barcode can be read by a smartphone app and then communicated to, for example, a public health authority. In theory, the technology would obviate the need to ship the test strips to a central lab; alternatively—and if temperature sensing is a requirement—that feature could be built in. The barcode enables consistent identification of the sample source.

Reference: Pharmaceutical Commerce - Business Strategies for Bio/Pharma Success

Ready to Get Started?

Learn how Varcode can enhance the value of your current investment in cold chain monitoring.

Request a Consultation